Literature DB >> 1369551

[Characterization of a human cell line from an anaplastic carcinoma of the thyroid gland].

J Gioanni1, E Zanghellini, C Mazeau, D Zhang, A Courdi, M Farges, J C Lambert, H Duplay, M Schneider.   

Abstract

A new cell line derived from a thyroid anaplastic carcinoma, CAL 62, has been established in culture. This line is constituted by highly tumorigenic cells. Their epithelial phenotype is stable in culture. Immunochemical staining for human thyroglobulin is negative. Cytogenetic analysis showed a gain of chromosome 20, the translocation i (14q), and breakpoints of centrometric chromatine. These results are similar to those previously reported by other investigators. CAL 62 radiosensibility has been studied. The survival curve of the in vitro irradiated cells has been adjusted with a linear-quadratic model. This cell line is thus showed to be radioresistant. Cell line CAL 62 constitutes an appropriate model for in vitro studies of thyroid anaplastic carcinoma.

Entities:  

Mesh:

Year:  1991        PMID: 1369551

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  9 in total

1.  Establishment and characterization of a human thyroid carcinoma cell line (HOTHC) producing colony stimulating factor.

Authors:  Isamu Ishiwata; Isao Ono; Kazushige Kiguchi; Chieko Ishiwata; Masayuki Soma; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

2.  Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts.

Authors:  Laura A Marlow; Stephen D Rohl; James L Miller; Jeffery A Knauf; James A Fagin; Mabel Ryder; Dragana Milosevic; Brian C Netzel; Stefan K Grebe; Honey V Reddi; Robert C Smallridge; John A Copland
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

Review 3.  Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Authors:  Tania Pilli; Kanteti V Prasad; Shankar Jayarama; Furio Pacini; Bellur S Prabhakar
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

4.  Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Authors:  Rebecca E Schweppe; Joshua P Klopper; Christopher Korch; Umarani Pugazhenthi; Miriam Benezra; Jeffrey A Knauf; James A Fagin; Laura A Marlow; John A Copland; Robert C Smallridge; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2008-08-19       Impact factor: 5.958

5.  DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.

Authors:  Camille Buffet; Karine Hecale-Perlemoine; Léopoldine Bricaire; Florent Dumont; Camille Baudry; Frédérique Tissier; Jérôme Bertherat; Beatrix Cochand-Priollet; Marie-Laure Raffin-Sanson; Françoise Cormier; Lionel Groussin
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

6.  Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness.

Authors:  Giovanna Revilla; Monica de Pablo Pons; Lucía Baila-Rueda; Annabel García-León; David Santos; Ana Cenarro; Marcelo Magalhaes; R M Blanco; Antonio Moral; José Ignacio Pérez; Gerard Sabé; Cintia González; Victoria Fuste; Enrique Lerma; Manuel Dos Santos Faria; Alberto de Leiva; Rosa Corcoy; Joan Carles Escolà-Gil; Eugenia Mato
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

7.  Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.

Authors:  Christian M Schürch; Matthias A Roelli; Stefan Forster; Marie-Hélène Wasmer; Frido Brühl; Renaud S Maire; Sergio Di Pancrazio; Marc-David Ruepp; Roland Giger; Aurel Perren; Anja M Schmitt; Philippe Krebs; Roch-Philippe Charles; Matthias S Dettmer
Journal:  Thyroid       Date:  2019-05-10       Impact factor: 6.568

8.  Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.

Authors:  Hannah R Nieto; Caitlin E M Thornton; Katie Brookes; Albert Nobre de Menezes; Alice Fletcher; Mohammed Alshahrani; Merve Kocbiyik; Neil Sharma; Kristien Boelaert; Jean-Baptiste Cazier; Hisham Mehanna; Vicki E Smith; Martin L Read; Christopher J McCabe
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

9.  Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin.

Authors:  D Spalletti-Cernia; R Sorrentino; S Di Gaetano; R Piccoli; M Santoro; G D'Alessio; P Laccetti; G Vecchio
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.